Parenteral iron use in the management of anemia in end-stage renal disease patients.
about
Determination of iron sucrose (Venofer) or iron dextran (DexFerrum) removal by hemodialysis: an in-vitro studyManaging hyperphosphatemia in patients with chronic kidney disease on dialysis with ferric citrate: latest evidence and clinical usefulnessPathogenesis of Shiga toxin-associated hemolytic uremic syndrome.Palliative care in inflammatory bowel disease: an evidence-based approach.Consequences and therapy of the metabolic acidosis of chronic kidney disease.Iron therapy for renal anemia: how much needed, how much harmful?Utilization Patterns of IV Iron and Erythropoiesis Stimulating Agents in Anemic Chronic Kidney Disease Patients: A Multihospital Study.Protein and energy depletion in chronic hemodialysis patients: clinical applicability of diagnostic tools.Challenges of providing nutrition support in the outpatient dialysis setting.Integrating clinical nutrition practice guidelines in chronic kidney disease.Selected pharmacokinetic issues in patients with chronic kidney disease.Safety issues with intravenous iron products in the management of anemia in chronic kidney diseaseDiets and enteral supplements for improving outcomes in chronic kidney disease.Nutrition in patients on peritoneal dialysis.NF-κB expression and its association with nutritional status in hemodialysis patients.Haemodialysis fluid: composition and clinical importance.Labile iron in parenteral iron formulations and its potential for generating plasma nontransferrin-bound iron in dialysis patients.Carnitine treatment improved quality-of-life measure in a sample of Midwestern hemodialysis patients.Effect of soya protein on serum lipid profile and lipoprotein concentrations in patients undergoing hypercholesterolaemic haemodialysis.Iron sucrose: assessing the similarity between the originator drug and its intended copies.Evaluation of Nutritional Status in Children during Predialysis, or Treated By Peritoneal Dialysis or Hemodialysis.Assessment of body composition in peritoneal dialysis patients using bioelectrical impedance and dual-energy x-ray absorptiometry.
P2860
Q24791511-10461E30-0D0F-4E96-92E3-43DA7710A615Q26786000-230F0F38-2C97-4F82-8009-72E39FB3FC16Q33338331-4A8C5886-1F2A-41C0-9771-25E2B017AEA6Q34015911-283D34B4-1EA2-4B0C-92FF-4F065A3FEF1DQ34347210-04D0C62C-E14C-47EC-849D-69E6B1D7A3C6Q35650627-533F1425-C04B-4D3D-9538-9A0016E38552Q35936604-FA88C0C6-282C-40F7-A24C-1829B9AB8A7BQ36278331-98717CDC-A80B-466C-9BF1-404598FDD660Q36278343-3A9D656C-CD0A-4F41-8327-6D073AFA6129Q36278348-31F62633-E270-4EC2-9536-DFE2BB00146FQ36684744-2003F5D5-E2FD-43EA-B3FF-A598C07A3A64Q37161960-553F4DCD-6C6A-4481-B4AA-E4155BFE1C3EQ37421911-CF6F59B4-1576-4509-BF14-879A028151F4Q37981901-2425D6A6-131E-4FBA-BB55-52DCA29FF059Q40563733-73300695-BD0F-4D95-AE05-D592B6264EAFQ43342185-B33493CC-7EB4-44D3-BE48-4AA9AF0D438AQ43910634-9F14E265-4584-4578-9903-1BEC0CFF33A5Q46875271-754A9FF7-CC35-45CD-B4AE-3E2BBAE43C50Q46936801-C37DA413-3A5F-4E1E-848F-8EB442C8FB33Q49720109-D5D43524-8DF1-4799-954A-8039F207E248Q52889174-36387754-806C-4BD9-B67E-3138618C33C4Q53080175-0CE6A57D-4DA3-4D5E-BC62-CB253BD18ACB
P2860
Parenteral iron use in the management of anemia in end-stage renal disease patients.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Parenteral iron use in the management of anemia in end-stage renal disease patients.
@ast
Parenteral iron use in the management of anemia in end-stage renal disease patients.
@en
type
label
Parenteral iron use in the management of anemia in end-stage renal disease patients.
@ast
Parenteral iron use in the management of anemia in end-stage renal disease patients.
@en
prefLabel
Parenteral iron use in the management of anemia in end-stage renal disease patients.
@ast
Parenteral iron use in the management of anemia in end-stage renal disease patients.
@en
P2093
P1476
Parenteral iron use in the management of anemia in end-stage renal disease patients.
@en
P2093
C A Johnson
G R Bailie
P356
10.1016/S0272-6386(00)70294-0
P577
2000-01-01T00:00:00Z